CMA clarifies cooperation on combination therapies to speed up patient access to vital treatments

The Competition and Markets Authority (CMA) has today issued a statement clarifying that certain types of engagements between competing drug firms working on ‘combination therapies’ will not be prioritized for investigation – making it easier for drug firms to work together to develop vital treatments for use in the NHS.

What could fix cancer clinical trials’ longstanding diversity problem?

There’s a diversity problem in cancer clinical trials, and few know this better than Stephanie Walker. When she was diagnosed with stage 4 metastatic breast

September 7, 2023

STD epidemic slows as new syphilis and gonorrhea cases fall in U.S.

The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday. The

November 12, 2024

Half-year financial statements close with balanced EBITDA, Trauma with positive EBITDA – Biotech Investments

EQS-News: aap Implantate AG / Key word(s): Half Year Results Half-year financial statements close with balanced EBITDA, Trauma with positive EBITDA 14.08.2024 / 19:15 CET/CEST

August 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.